Navigation Links
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Date:6/12/2008

ent platform leader for musculoskeletal and Cialis platform. "As we focus on developing a transdermal PTH product with TransPharma, we will leverage our combined expertise, with the goal of providing patients with a product that meets their desire for an alternative to injection for PTH."

"We are extremely pleased to partner with Lilly, a leading player in the osteoporosis market," said Dr. Daphna Heffetz, CEO of TransPharma Medical. "This collaboration is an excellent example for how our transdermal ViaDerm-based products may deliver added value to promising drug compounds. We are confident that Lilly's experience and outstanding drug development capabilities together with our innovative technology could propel our joint ViaDerm-PTH (1-34) product as an improved therapy for people suffering from osteoporosis."

About ViaDerm Drug Delivery System

TransPharma's ViaDerm drug delivery system incorporates a handheld electronic control unit, which creates microscopic passageways through the outer layer of the skin allowing for transdermal delivery of a wide variety of drugs from a patch. The system provides a cost-effective, easy-to-use, self-administered solution that enables the safe, reproducible and accurate delivery of a broad range of product candidates, including hydrophilic small molecules peptides and proteins.

About Osteoporosis

Osteoporosis is a debilitating disease that affects an estimated 75 million people in Europe, the U.S. and Japan.(i) Osteoporosis, which means "porous bone," is a disease in which the density and quality of bone are reduced. As the bones become more porous and fragile, the risk of fracture is greatly increased. The loss of bone occurs "silently" and progressively and no symptoms are apparent until the first fracture occurs.(ii)

The most common fractures associated with osteoporosis occur at the hip, spine and wrist. The incidence of these fractures, particularly at the hip and spine, increases wi
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... researchers with EDP Biotech Corporation (EDP) have captured ... a simple blood test to detect early-stage colon ... its pre-clinical trials for the ColoMarker(TM) assay, EDP ... and all aspects of its use. Via ... cancer in its earliest, most curable stages. ,, ...
(Date:12/15/2009)... Tenn., Dec. 15 Cumberland Pharmaceuticals ... announced new top-line results for a patient ... Oral Solution, a prescription laxative packaged as a ... forms. ,, Kristalose is the only prescription-strength laxative ... period, 50 patients with a recent diagnosis of ...
(Date:12/15/2009)... Dec. 15 Today,s New ... "Plan for Kidney Drugs Spurs Division," illustrates an ... in kidney patients continuing to be deprived of ... Medicare program limit. ,, As Congress is poised ... preserve the lives of transplant kidney recipients, behind-the-scenes ...
Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 1Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 4Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 5Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 6Chimerix to Present at Two Upcoming Investor Conferences 6195 1Chimerix to Present at Two Upcoming Investor Conferences 6195 2Behavior modification could ease concerns about nanoparticles 10701 1Behavior modification could ease concerns about nanoparticles 10701 2
... and Specific Molecular Structures Needed for siRNA ... ... Silence Therapeutics plc,(AIM:SLN) Europe,s leading RNAi-focused biotechnology company, today,comments on ... via TLR3" Mark E.,Kleinman, et. al., and Molecules and Cells(2) ...
... Data from five studies sponsored,by Ortho Biotech ... Kidney,Foundation (NKF) 2008 Spring Clinical Meetings from April ... (Epoetin alfa)., The data include studies that ... and darbepoetin alfa (DARB), evaluate medical costs,related to ...
Other Medicine Technology:Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 2Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 3Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 2Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 3Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 5Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 6
(Date:12/15/2009)... it,s still too early to say that ... TUESDAY, Dec. 15 (HealthDay News) -- Common chemicals ... to the abnormal growth of breasts in boys, ... in a prominent medical journal for pediatricians, adds ... phthalates, whose safety has been questioned by some ...
(Date:12/15/2009)... a leading provider of secure USB devices, today launches SafeConsole ... flash drive. The software is designed to provide better usability ... of new features and range of licensing options. , ... ... -- BlockMaster ( www.blockmastersecurity.com ) a leading provider of secure ...
(Date:12/15/2009)... goes up within a week of getting news, ... -- Emotional stress can put newly diagnosed prostate ... and suicide, a new study has found. , ... with prostate cancer between 1961 and 2004. Of ... event within a year of cancer diagnosis and ...
(Date:12/15/2009)... Accelify is proud to announce the addition of David ... serve as Director of Development in the State of ... Advisors. ,, David Tokofsky was elected to ... in June 1995. As the Board Member for District ... from Northeast Los Angeles through East Los Angeles to ...
(Date:12/15/2009)... Health Technologies, Inc. (OTC Bulletin Board: VHGI) confirmed ... subsidiary of VHGI) has appointed two key industry ... with bringing the Treasure Gulch and Zero Gold ... Additionally, the company is informing interested shareholders and ... Live Investor Town Hall Meeting so that investors ...
Breaking Medicine News(10 mins):Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 3Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 4Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 5
... 25 Musketeer Group, Inc. and Coalition,America, Inc. ... unique,repricing solution for Musketeer customers. The partnership streamlines ... greater,administrative and medical claim savings. CAI,s integration with ... claims,as well as expedited adjudication of repriced claims. ...
... American Society,for Therapeutic Radiology and Oncology has published ... Gynecologic Cancers. The brochure,provides women coping with a ... radiation therapy and their treatment options, as well,as ... how to care for,themselves while undergoing treatment. ...
... Diego, September 25, 2007 Some people are caught ... own abuse as a child and continuing into perpetration ... it is important to understand how childhood experiences are ... published in the October issue of the American Journal ...
... in The Netherlands have developed a method of accurately ... to have their disease recur after surgery and who ... , Led by Professor Rob Tollenaar at Leiden University ... The Netherlands Cancer Institute, they have analysed for the ...
... Wash., Sept. 25 Cardiac Science,Corporation (Nasdaq: ... advanced cardiac monitoring,and defibrillation products, today applauded ... lay rescuers from the Pittsburgh school district ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ) Cardiac ...
... Mass., Sept. 25 CutisPharma, Inc. has ... as its preferred,vendor for unit-of-use compounding kits. ... Shoppe(R) and Medicap Pharmacy(R) franchisees the ability ... pharmacies already providing the,service, to increase the ...
Other Medicine News:Health News:Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators 2Health News:Updated Brochure on Gynecologic Cancer Treatments Now Available 2Health News:Victims of child maltreatment more likely to perpetrate youth violence, intimate partner violence 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 2Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 4Health News:CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits 2Health News:CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits 3
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. A shoulder drop-away can also be used with our Stretchy-back and cummmberbund aprons. Shoulder pads and hangi...
Open armhole design with Velcro release enables removal without compromising sterile field. Loops attached at shoulders for proper hanging & storage...
This apron provides full protection all the way around. Extra wide Velcro strips provide many adjustments and a secure fit....
Unique criss-cross strapping distributes weight evenly over the torso for ultimate comfort and flexibility. Fully adjustable 2 inch belt and buckle for easy front closure....
Medicine Products: